The Globe and Mail reports in its Friday, Jan. 17, edition that Canaccord Genuity analyst Aravinda Galappatthige has reaffirmed his "buy" recommendation for Cineplex. The Globe's David Leeder writes in the Eye On Equities column that Mr. Galappatthige boosted his share target by a loonie to $12.50. Analysts on average target the shares at $13.85. Mr. Galappatthige says in a note: "Following the release of its December box office update, we have revised our estimates for both F2024 and F2025, and introduced F2026 estimates. At a high level, we see F2025 as a year in which Cineplex s financials could revert back to some normalcy on a full-year basis following the impact of the Hollywood strikes which were felt through H1/24. Thereby, F2025 could serve as a more reliable basis for valuing the stock. Overall, we see F2025 FCF rising above $1/sh for the first time since the pandemic with adjusted EBITDA reaching 75 per cent of prepandemic levels. This translates to a healthy 9-per-cent FCF yield." The Globe reported on Jan. 19, 2023, and Feb. 9, 2023, that Canaccord Genuity analyst Aravinda Galappatthige was sticking with his "buy" recommendation for Cineplex when it could be had for $7.92 and $8.91.